Location: Home
  • search
  • go
  • Relate News
  • 4/1/2021Patent Term Extension and Patent Linkage for Pharmaceutical Patents in...
  • 3/31/2021China's Healthcare System: Addressing Capacity Shortfalls before and a...
  • 3/31/2021Everest Medicines Granted Clinical Trial Approval to Evaluate Trodelv...
  • 3/31/2021Albumedix Enters Recombinant Human Albumin Supply Partnership with FU...
  • 3/31/2021Eucure Bio Announces Breakthru Phase I Results for Anti-CTLA-4 Therapy...
  • 3/31/2021CDE Solicits Comments on Three Technical Guidelines for Nanomedicines
  • 3/31/2021Financial-related Company News in Brief
  • 3/30/2021China Plans "Unprecedented" Investment into TCM with Doubling Budget i...
  • 3/30/2021Henlius and NeuPharma Enter License Deal for BRAF V600E Inhibitor
  • 3/30/2021BMS and Huyabio Enter Global Clinical Trial Collaboration for Melanoma...
  • 3/30/2021Snapshot of Chinese VMS OTC Market in 2020
  • 3/30/2021PharmaDJ's China Market Approval Tracker: Feb 2021
  • 3/29/2021Outlook of Chinese Biopharma Industry in 2021: Growth and Differentiat...
  • 3/29/2021CDE Issues the Technical Guidelines for Drug Immunogenicity Research
  • 3/29/2021HutchMed Initiates International Studies of IDH Inhibitor HMPL-306
  • 3/29/2021Kazia Licenses Rights to Paxalisib in Greater China to Simcere
  • 3/26/2021Boehringer Ingelheim Witness Sharp Growth in China Last Year
  • 3/26/2021Kyowa Hakko Kirin Granted Chinese Approval for Additional Indication o...
  • 3/26/2021Recent Executive Moves
  • 3/25/2021Eli Lilly and Innovent Jointly Launched TYVYT (sintilimab injection) f...
  • 3/25/2021CPIA Introduces the Pharmaceutical Industry Compliance Code
  • 3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine
  • 3/24/2021HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combo with Ti...
  • 3/24/2021China Declares Early Success in Expanding Online Medical Services
  • 3/24/2021BMS to Offer Steeper Discount for Opdivo in China, Cutting Price to ...
  • 3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M
  • 3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...
  • 3/24/2021Pharma Manufacturing Industry Lag and Potential for China's Five-Year ...
  • 3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...
  • 3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...
  • Page:70/333 Total number of articles:9989: [First][<<] [68] [69] [70] [71] [72] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group